Blackstone Inc’s Abivax ABVX Stock Holding History
Bought
Maintained
Sold
Other funds holding ABVX
TCM
DTC
ACM
CAM
GPP
NCM
VA
CP
Blackstone Inc's ABVX Position: Q1 2025 in Review
Blackstone Inc sold out of Abivax (ABVX) in Q1 2025, closing a stake of 936,607 shares — an estimated $6.86M sold.
Blackstone Inc first reported a position in ABVX in Q4 2023 and held it in 5 quarters. The position peaked at $30.3M in Q1 2024. 46 funds tracked by Wall St. Rank hold ABVX as of Q1 2025.
- Blackstone Inc reported no remaining Abivax position as of Q1 2025 after selling out during the quarter.
- Blackstone Inc sold 936,607 Abivax shares in Q1 2025, an estimated $6.86M.
- Blackstone Inc first reported a position in Abivax in Q4 2023 and held it in 5 quarters.
- Blackstone Inc's Abivax position peaked at $30.3M in Q1 2024.
- 46 funds tracked by Wall St. Rank held Abivax as of Q1 2025.
Based on Blackstone Inc's 13F filing for Q1 2025, filed 15 May 2025.